Neuphoria Therapeutics Inc. (NEUP) AI Dilution Summary

Cash was $19,865,531 at 2026-06-30, against estimated monthly burn of $1,029,423. The active funding channel is an at-the-market program with H.C. Wainwright & Co., LLC, authorised to $20,000,000; sales through a stated date are not disclosed in the filings reviewed. The main source of dilution is that ATM program.